Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 692

1.

Impact of race/ethnicity on insulin resistance and hypertriglyceridaemia.

Raygor V, Abbasi F, Lazzeroni LC, Kim S, Ingelsson E, Reaven GM, Knowles JW.

Diab Vasc Dis Res. 2019 Mar;16(2):153-159. doi: 10.1177/1479164118813890.

PMID:
31014093
2.

Plasma glucose concentration 60 min post oral glucose load and risk of type 2 diabetes and cardiovascular disease: Pathophysiological implications.

Abbasi F, Tern PJ, Reaven GM.

Diab Vasc Dis Res. 2019 Jul;16(4):337-343. doi: 10.1177/1479164119827239. Epub 2019 Feb 13.

PMID:
30755013
3.

Can the Plasma Concentration Ratio of Triglyceride/High-Density Lipoprotein Cholesterol Identify Individuals at High Risk of Cardiovascular Disease During 40-Year Follow-Up?

Lind L, Ingelsson E, Ärnlöv J, Sundström J, Zethelius B, Reaven GM.

Metab Syndr Relat Disord. 2018 Oct;16(8):433-439. doi: 10.1089/met.2018.0058. Epub 2018 Sep 5.

PMID:
30183521
4.

Relationship between several surrogate estimates of insulin resistance and a direct measure of insulin-mediated glucose disposal: Comparison of fasting versus post-glucose load measurements.

Abbasi F, Silvers A, Viren J, Reaven GM.

Diabetes Res Clin Pract. 2018 Feb;136:108-115. doi: 10.1016/j.diabres.2017.11.021. Epub 2017 Dec 2.

PMID:
29203256
5.

Adapting to insulin resistance in obesity: role of insulin secretion and clearance.

Jung SH, Jung CH, Reaven GM, Kim SH.

Diabetologia. 2018 Mar;61(3):681-687. doi: 10.1007/s00125-017-4511-0. Epub 2017 Dec 1.

6.

Relationship between simple markers of insulin resistance and coronary artery calcification.

Reaven GM, Knowles JW, Leonard D, Barlow CE, Willis BL, Haskell WL, Maron DJ.

J Clin Lipidol. 2017 Jul - Aug;11(4):1007-1012. doi: 10.1016/j.jacl.2017.05.013. Epub 2017 Jun 6.

7.

Cardiovascular disease in PCOS is related to severe insulin resistance, not mild.

Dahan MH, Abbasi F, Reaven GM.

Minerva Endocrinol. 2017 Sep;42(3):294-296. doi: 10.23736/S0391-1977.16.02482-2. No abstract available.

8.

Relationship among age, insulin resistance, and blood pressure.

Jung CH, Jung SH, Lee B, Rosenberg M, Reaven GM, Kim SH.

J Am Soc Hypertens. 2017 Jun;11(6):359-365.e2. doi: 10.1016/j.jash.2017.04.005. Epub 2017 Apr 14.

9.

Comparison of two surrogate estimates of insulin resistance to predict cardiovascular disease in apparently healthy individuals.

Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Dulbecco CA, Reaven GM.

Nutr Metab Cardiovasc Dis. 2017 Apr;27(4):366-373. doi: 10.1016/j.numecd.2016.12.002. Epub 2016 Dec 24.

PMID:
28254109
10.

Effect of Pioglitazone on Cardiometabolic Risk in Patients With Obstructive Sleep Apnea.

Liu A, Abbasi F, Kim SH, Ariel D, Lamendola C, Cardell J, Xu S, Patel S, Tomasso V, Mojaddidi H, Grove K, Tsao PS, Kushida CA, Reaven GM.

Am J Cardiol. 2017 Apr 15;119(8):1205-1210. doi: 10.1016/j.amjcard.2016.12.034. Epub 2017 Jan 25.

11.

Analysis of Transcriptional Variability in a Large Human iPSC Library Reveals Genetic and Non-genetic Determinants of Heterogeneity.

Carcamo-Orive I, Hoffman GE, Cundiff P, Beckmann ND, D'Souza SL, Knowles JW, Patel A, Papatsenko D, Abbasi F, Reaven GM, Whalen S, Lee P, Shahbazi M, Henrion MYR, Zhu K, Wang S, Roussos P, Schadt EE, Pandey G, Chang R, Quertermous T, Lemischka I.

Cell Stem Cell. 2017 Apr 6;20(4):518-532.e9. doi: 10.1016/j.stem.2016.11.005. Epub 2016 Dec 22.

12.

Dissecting the relationship between obesity and hyperinsulinemia: Role of insulin secretion and insulin clearance.

Kim MK, Reaven GM, Kim SH.

Obesity (Silver Spring). 2017 Feb;25(2):378-383. doi: 10.1002/oby.21699. Epub 2016 Dec 21.

13.

Use of the triglyceride/high-density lipoprotein cholesterol ratio to identify cardiometabolic risk: impact of obesity?

Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Marillet AG, Leiva Sisnieguez CE, Leiva Sisnieguez BC, Stavile RN, March CE, Reaven GM.

J Investig Med. 2017 Feb;65(2):323-327. doi: 10.1136/jim-2016-000248. Epub 2016 Sep 16.

PMID:
27638846
14.

Hypertriglyceridemia: A simple approach to identify insulin resistance and enhanced cardio-metabolic risk in patients with prediabetes.

Abbasi F, Kohli P, Reaven GM, Knowles JW.

Diabetes Res Clin Pract. 2016 Oct;120:156-61. doi: 10.1016/j.diabres.2016.07.024. Epub 2016 Aug 6.

PMID:
27565692
15.

Does enhanced insulin sensitivity improve sleep measures in patients with obstructive sleep apnea: a randomized, placebo-controlled pilot study.

Liu A, Kim SH, Ariel D, Abbasi F, Lamendola C, Cardell J, Xu S, Patel S, Tomasso V, Mojaddidi H, Grove K, Tsao PS, Kushida CA, Reaven GM.

Sleep Med. 2016 Jun;22:57-60. doi: 10.1016/j.sleep.2016.06.005. Epub 2016 Jun 21.

16.

Statins, familial hypercholesterolemia, and type 2 diabetes.

Reaven GM.

J Intern Med. 2016 Oct;280(4):421-2. doi: 10.1111/joim.12537. Epub 2016 Jul 25. No abstract available.

17.

Insulin clearance: an underappreciated modulator of plasma insulin concentration.

Kim SH, Reaven GM.

J Investig Med. 2016 Oct;64(7):1162-5. doi: 10.1136/jim-2016-000149. Epub 2016 May 26. Review.

PMID:
27229887
18.

Cardiometabolic Risk in South Asian Inhabitants of California: Hypertriglyceridemic Waist vs Hypertriglyceridemic Body Mass Index.

Abbasi F, Mathur A, Reaven GM, Molina CR.

Ethn Dis. 2016 Apr 21;26(2):191-6. doi: 10.18865/ed.26.2.191.

19.

Insulin resistance: The linchpin between prediabetes and cardiovascular disease.

Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Leiva Sisnieguez CE, Leiva Sisnieguez BC, Stavile RN, March CE, Reaven GM.

Diab Vasc Dis Res. 2016 Mar;13(2):157-63. doi: 10.1177/1479164115610057. Epub 2016 Jan 22.

PMID:
26802220
20.

Relationship between insulin sensitivity and insulin secretion rate: not necessarily hyperbolic.

Kim SH, Silvers A, Viren J, Reaven GM.

Diabet Med. 2016 Jul;33(7):961-7. doi: 10.1111/dme.13055. Epub 2016 Jan 10.

21.

Hyperinsulinemia in individuals with obesity: Role of insulin clearance.

Kim MK, Reaven GM, Chen YD, Kim E, Kim SH.

Obesity (Silver Spring). 2015 Dec;23(12):2430-4. doi: 10.1002/oby.21256. Epub 2015 Nov 2.

22.

Comparison of the association with sleep apnoea of obesity versus insulin resistance.

Liu A, Ariel D, Lamendola C, Kim SH, Abbasi F, Cardell J, Tomasso V, Mojaddidi H, Grove K, Kushida CA, Reaven GM.

Eur Respir J. 2015 Dec;46(6):1829-32. doi: 10.1183/13993003.01087-2015. Epub 2015 Sep 24. No abstract available.

23.

Salsalate-induced changes in lipid, lipoprotein, and apoprotein concentrations in overweight or obese, insulin-resistant, nondiabetic individuals.

Ariel D, Kim SH, Liu A, Abbasi F, Lamendola CA, Grove K, Tomasso V, Reaven GM.

J Clin Lipidol. 2015 Sep-Oct;9(5):658-63. doi: 10.1016/j.jacl.2015.06.009. Epub 2015 Jun 18.

24.

The Reply.

Salazar MR, Reaven GM.

Am J Med. 2015 Jul;128(7):e27. doi: 10.1016/j.amjmed.2015.03.017. No abstract available.

PMID:
26092075
25.

Circulating microRNA-320a and microRNA-486 predict thiazolidinedione response: Moving towards precision health for diabetes prevention.

Flowers E, Aouizerat BE, Abbasi F, Lamendola C, Grove KM, Fukuoka Y, Reaven GM.

Metabolism. 2015 Sep;64(9):1051-9. doi: 10.1016/j.metabol.2015.05.013. Epub 2015 May 28.

26.

Usefulness of fetuin-A to predict risk for cardiovascular disease among patients with obstructive sleep apnea.

Liu A, Lamendola C, Ariel D, Abbasi F, Kim SH, Cardell J, Tomasso V, Xu S, Patel S, Mojaddidi H, Grove K, Kushida CA, Reaven GM.

Am J Cardiol. 2015 Jul 15;116(2):219-24. doi: 10.1016/j.amjcard.2015.04.014. Epub 2015 Apr 18.

27.
28.

Low circulating 25-hydroxyvitamin D concentrations are associated with defects in insulin action and insulin secretion in persons with prediabetes.

Abbasi F, Blasey C, Feldman D, Caulfield MP, Hantash FM, Reaven GM.

J Nutr. 2015 Apr;145(4):714-9. doi: 10.3945/jn.114.209171. Epub 2015 Mar 4.

29.

Use of the plasma triglyceride/high-density lipoprotein cholesterol ratio to identify cardiovascular disease in hypertensive subjects.

Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Leiva Sisnieguez CE, Leiva Sisnieguez BC, March CE, Stavile RN, Balbín E, Reaven GM.

J Am Soc Hypertens. 2014 Oct;8(10):724-31. doi: 10.1016/j.jash.2014.08.002. Epub 2014 Aug 14.

PMID:
25418494
30.

Abnormalities of lipoprotein concentrations in obstructive sleep apnea are related to insulin resistance.

Liu A, Cardell J, Ariel D, Lamendola C, Abbasi F, Kim SH, Holmes TH, Tomasso V, Mojaddidi H, Grove K, Kushida CA, Reaven GM.

Sleep. 2015 May 1;38(5):793-9. doi: 10.5665/sleep.4678.

31.

Effect of liraglutide administration and a calorie-restricted diet on lipoprotein profile in overweight/obese persons with prediabetes.

Ariel D, Kim SH, Abbasi F, Lamendola CA, Liu A, Reaven GM.

Nutr Metab Cardiovasc Dis. 2014 Dec;24(12):1317-22. doi: 10.1016/j.numecd.2014.06.010. Epub 2014 Jun 28.

PMID:
25280957
32.

Statin-induced diabetes: how important is insulin resistance?

Abbasi F, Reaven GM.

J Intern Med. 2015 Apr;277(4):498-500. doi: 10.1111/joim.12297. Epub 2014 Sep 25. No abstract available.

33.

Relationship among 25-hydroxyvitamin D concentrations, insulin action, and cardiovascular disease risk in patients with essential hypertension.

Abbasi F, Feldman D, Caulfield MP, Hantash FM, Reaven GM.

Am J Hypertens. 2015 Feb;28(2):266-72. doi: 10.1093/ajh/hpu136. Epub 2014 Aug 19.

34.

Do differences in waist circumference modify the relationships among body mass index, insulin resistance, and related cardiometabolic risk factors in apparently healthy women?

Salazar MR, Carbajal HA, Espeche WG, Balbín E, Aizpurúa M, Marillet AG, Reaven GM.

J Am Coll Nutr. 2014;33(1):32-8. doi: 10.1080/07315724.2014.869982.

PMID:
24533606
35.

Identification of cardiometabolic risk: visceral adiposity index versus triglyceride/HDL cholesterol ratio.

Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Maciel PM, Reaven GM.

Am J Med. 2014 Feb;127(2):152-7. doi: 10.1016/j.amjmed.2013.10.012. Epub 2013 Nov 1.

PMID:
24462013
36.

Reply to DN Polesel et al.

Liu A, Reaven GM, Abbasi F.

Am J Clin Nutr. 2013 Dec;98(6):1593. doi: 10.3945/ajcn.113.072876. No abstract available.

37.

Adiposity and cardiovascular risk clustering in South Asians.

Flowers E, Molina C, Mathur A, Reaven GM.

Metab Syndr Relat Disord. 2013 Dec;11(6):434-40. doi: 10.1089/met.2013.0081. Epub 2013 Sep 4.

38.

Cardiometabolic risk factors and obesity: does it matter whether BMI or waist circumference is the index of obesity?

Abbasi F, Blasey C, Reaven GM.

Am J Clin Nutr. 2013 Sep;98(3):637-40. doi: 10.3945/ajcn.112.047506. Epub 2013 Jul 24.

39.

Plasma triglyceride/HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults.

Murguía-Romero M, Jiménez-Flores JR, Sigrist-Flores SC, Espinoza-Camacho MA, Jiménez-Morales M, Piña E, Méndez-Cruz AR, Villalobos-Molina R, Reaven GM.

J Lipid Res. 2013 Oct;54(10):2795-9. doi: 10.1194/jlr.M040584. Epub 2013 Jul 17.

40.

Habitual shortened sleep and insulin resistance: an independent relationship in obese individuals.

Liu A, Kushida CA, Reaven GM.

Metabolism. 2013 Nov;62(11):1553-6. doi: 10.1016/j.metabol.2013.06.003. Epub 2013 Jul 10.

41.

Beyond fasting plasma glucose: the association between coronary heart disease risk and postprandial glucose, postprandial insulin and insulin resistance in healthy, nondiabetic adults.

Bhat SL, Abbasi FA, Blasey C, Reaven GM, Kim SH.

Metabolism. 2013 Sep;62(9):1223-6. doi: 10.1016/j.metabol.2013.04.012. Epub 2013 Jun 27.

PMID:
23809477
42.

What do we learn from measurements of HOMA-IR?

Reaven GM.

Diabetologia. 2013 Aug;56(8):1867-8. doi: 10.1007/s00125-013-2948-3. Epub 2013 May 31. No abstract available.

PMID:
23722624
43.

Comparison of the abilities of the plasma triglyceride/high-density lipoprotein cholesterol ratio and the metabolic syndrome to identify insulin resistance.

Salazar MR, Carbajal HA, Espeche WG, Leiva Sisnieguez CE, March CE, Balbín E, Dulbecco CA, Aizpurúa M, Marillet AG, Reaven GM.

Diab Vasc Dis Res. 2013 Jul;10(4):346-52. doi: 10.1177/1479164113479809. Epub 2013 Apr 26.

44.
45.

Is measurement of non-HDL cholesterol an effective way to identify the metabolic syndrome?

Liu A, Reaven GM.

Nutr Metab Cardiovasc Dis. 2013 Nov;23(11):1122-7. doi: 10.1016/j.numecd.2012.12.001. Epub 2013 Jan 24.

46.

Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.

Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Leiva Sisnieguez CE, March CE, Balbín E, Stavile RN, Reaven GM.

J Intern Med. 2013 Jun;273(6):595-601. doi: 10.1111/joim.12036. Epub 2013 Feb 18.

47.

Measurement of insulin-mediated glucose uptake: direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp.

Knowles JW, Assimes TL, Tsao PS, Natali A, Mari A, Quertermous T, Reaven GM, Abbasi F.

Metabolism. 2013 Apr;62(4):548-53. doi: 10.1016/j.metabol.2012.10.002. Epub 2012 Nov 12. Erratum in: Metabolism. 2014 Mar;63(3):e3.

48.

Risk for obstructive sleep apnea in obese, nondiabetic adults varies with insulin resistance status.

Liu A, Kushida CA, Reaven GM.

Sleep Breath. 2013 Mar;17(1):333-8. doi: 10.1007/s11325-012-0696-0. Epub 2012 Apr 7.

49.

Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women.

Salazar MR, Carbajal HA, Espeche WG, Leiva Sisnieguez CE, Balbín E, Dulbecco CA, Aizpurúa M, Marillet AG, Reaven GM.

Am J Cardiol. 2012 Jun 15;109(12):1749-53. doi: 10.1016/j.amjcard.2012.02.016. Epub 2012 Mar 24.

PMID:
22449634
50.

Relations between obesity, insulin resistance, and 25-hydroxyvitamin D.

Lamendola CA, Ariel D, Feldman D, Reaven GM.

Am J Clin Nutr. 2012 May;95(5):1055-9. doi: 10.3945/ajcn.111.032060. Epub 2012 Mar 21.

Supplemental Content

Loading ...
Support Center